Monte Rosa Therapeutics (GLUE) Net Income (QoQ) (2020 - 2026)
Monte Rosa Therapeutics (GLUE) Net Income (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - |
| 10 | Monte Rosa Therapeutics | 2.30 Bn | 1.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.08% |
| Dec 31, 2025 | -8.89% |
| Sep 30, 2025 | -120.26% |
| Jun 30, 2025 | -126.22% |
| Mar 31, 2025 | 52.55% |
| Dec 31, 2024 | 228.82% |
| Sep 30, 2024 | 21.28% |
| Jun 30, 2024 | 5.24% |
| Mar 31, 2024 | 3.81% |
| Dec 31, 2023 | 4.68% |
| Sep 30, 2023 | 0.84% |
| Jun 30, 2023 | -9.80% |
| Mar 31, 2023 | -4.08% |
| Dec 31, 2022 | -12.68% |
| Sep 30, 2022 | -3.21% |
| Jun 30, 2022 | 59.17% |
| Mar 31, 2022 | -57.47% |
| Dec 31, 2021 | 59.66% |
| Sep 30, 2021 | 0.73% |
| Jun 30, 2021 | -793.59% |